WHAT IS REGENERATIVE THERAPY?
Regenerative Therapy is the Future of Healthcare.

Scroll down

Regenerative Therapy Definition and Types

Regenerative therapy is a cellular-level therapy that aims to improve the function of damaged or diseased tissue or organs by introducing cells to replace or repair damaged cells. Today, regenerative therapies are being recognized for their therapeutic potential for a wide variety of medical conditions across a range of specialties, including orthopedics, rheumatology, cardiology, neurology, immunology, and much more.

Because of their ability to differentiate into cells that carry out the roles needed in a variety of bodily functions; cellular allografts are an essential regenerative tool. When these allografts are introduced into damaged tissue or organ, they have the ability to evolve and carry out necessary functions, repairing or compensating for the damaged cells. As a minimally invasive process, regenerative therapy harnesses the natural capabilities of regenerative allografts and the body’s own ability to heal, providing an opportunity to avoid painful and invasive procedures.  
Embryonic stem cells
Stem_cells_2

Scope of Regenerative Therapy

Cell allografts, that occur naturally in the body, are “naive” or unspecialized. This means that, based on cues from their environment, these cells have the ability to transform into and assume the functions of a variety of different cells and cell types in the body. The ability to mature in a context-specific way is the key to the vast potential of cells in regenerative therapies. When introduced into damaged tissue, the cells can specialize and carry out their necessary functions in that particular area, potentially improving symptoms and function.

Scope of Regenerative Therapy

Cell allografts, that occur naturally in the body, are “naive” or unspecialized. This means that, based on cues from their environment, these cells have the ability to transform into and assume the functions of a variety of different cells and cell types in the body. The ability to mature in a context-specific way is the key to the vast potential of cells in regenerative therapies. When introduced into damaged tissue, the cells can specialize and carry out their necessary functions in that particular area, potentially improving symptoms and function.

What Makes MSC's Different

Hover over boxes to see content

Migration

MSCs have a special ability to move to specific tissues, going where the body needs them most. This means that the cells can be injected into the bloodstream to then move on their own to the affected area.

Repair

In the case of tissue damage, MSCs have the ability to release growth factors and specialize into a number of tissue cell types that allow for the tissue to be regenerated.

Immunomodulation

When foreign cells are introduced in the body, the concern is that they will often generate an immune response. Because MSCs express very few antigens on their surfaces that can generate an immune response (like MHCI or MHCII), they do not elicit a reaction from the patient’s immune system T-cells, making them safe to use.

Reduction of Inflammation

MSCs reduce the signal cells that promote inflammation (like TNF-alpha and TNF-gamma). While this is another function that helps them to avoid the immune response, it is also essential to the cells’ utility in chronic and autoimmune diseases characterized by inflammation.

Where Do Our Products Come From

While regenerative cells are found throughout the body, the cells used in medicine today may be derived from four different sources: umbilical cord tissue, embryonic tissue, bone marrow aspirate, and adipose tissue. However, some sources have their drawbacks. Embryonic cells raise ethical concerns, while bone marrow and adipose tissue-derived products can only be retrieved through invasive surgical procedures and have a significantly lower yield.

Considering this, BioGenix uses exclusively umbilical cord-derived products. Umbilical cord tissue retrieval, which takes place immediately after the umbilical cord is cut upon delivery, is non-invasive and ethically sound. In addition, umbilical cord tissue products have the highest product yield and are the best source of growth factors and cytokines that have an important role in regenerative therapies.

How Regenerative Therapy Works

Click the circles to see content

1. Respond
When an area of the body is injured or not functioning properly, distress signals are sent through the bloodstream. These signals serve to recruit cells to the affected area.
2. Dock
Once in the affected area, the cells dock on other cells and begin to produce signaling proteins that work to regulate inflammation, aid in angiogenesis, and promote tissue repair.​
3. Specialize
Cells then mature to carry out the functions of the cells that are needed. In this way, they compensate for the cells that are damaged, nonfunctional, or lacking to improve organ function, and consequently improve disease symptoms.

INTERESTED IN LEARNING MORE?

We partner with clinicians and institutions all over the world, introducing them to the potential of regenerative therapy and show them how they can harness the power of the latest regenerative technology to improve patient care and their quality of life.

Disclaimer: For Medical Professionals Only

This website is intended to inform and educate medical professionals. It is NOT intended for patients. It also does not seek to make claims about the effectiveness of regenerative medicine and its respective therapies in medical treatment.

Regenerative therapies have great potential in helping treat a range of conditions. This site serves to inform medical professionals about regenerative medicine, BioGenix allograft products, and key in vitro, animal model, and clinical research studies that have been carried out to date across medical specialties and health conditions. However, regenerative medicine is an early and evolving field, and clinical studies are still insufficient to determine effectiveness.

While the BioGenix products are produced in an FDA compliant laboratory, it has not been approved by the FDA for treatment effectiveness. The FDA states:

Like other medical products that are intended to treat, cure or prevent disease, generally require FDA approval before they can be marketed. FDA has not approved any stem cell-based products for use, other than cord blood-derived hematopoietic progenitor cells (blood-forming stem cells) for certain indications.

Patients interested in regenerative therapy in the U.S. are advised to consult a physician about the state of FDA approval for any given product and/or inquire about opportunities to participate in a clinical trial. Patients interested in regenerative therapies outside the U.S. should investigate regulations in the specific country. It is important to be aware that regulations and clinical study requirements vary from country to country.

By clicking yes you confirm that you are a medical professional, understand that the information contained in this website is intended for medical professionals and not for the general public, and have read and understood the disclaimer above.